Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device
NCT ID: NCT01944345
Last Updated: 2016-05-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
69 participants
OBSERVATIONAL
2013-06-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Interbody Fusion Device Patient Registry
NCT05114356
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
NCT00738439
A Clinical Registry to Track the Real World Use of the Saber-C® Cervical Fusion Device
NCT06240221
Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System
NCT00726128
RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures
NCT04821739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Follow up visits will be defined by the treating physicians based on their standard practice. Typical clinical follow up schedules for patients undergoing this type of surgery are pre-operative and 12 months post-operative.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* This is the first surgery at the index level
* Patient has understood and signed the informed consent
* Patient is skeletally mature
Exclusion Criteria
* Is a Worker's Compensation Case
* Infection at the operative site
* Sustained trauma with instability
* Sustained fracture of the vertebra at any of the lumbar spinal levels
* Has a primary diagnosis of degenerative or isthmic spondylolisthesis greater than Grade 1
* Physically or mentally compromised (i.e., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease, presence of alcohol or drug abuse)
* Has a diagnosed systemic disease that would affect the subject's welfare or overall outcome of the clinical study (i.e., moderate to severe osteoporosis, Paget's disease, renal osteodystrophy, metastasis to vertebrae, adult onset diabetes, active rheumatoid arthritis, etc.)
* Is an immunologically suppressed or receiving steroid in excess of usual doses
* Is obese (as defined by a Body Mass Index (BMI) of \> 40 kg/m2 (BMI equals (weight in pounds x 703) / (height in inches x height in inches))
* Has disabling and daily narcotic dependency greater than 18 months
* Has a known malignancy
* Has a known allergy to metal implants
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzel Spine
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Warren Neely, MD
Role: PRINCIPAL_INVESTIGATOR
The Methodist Hospital Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Foundation Surgical Hospital
San Antonio, Texas, United States
Methodist Hospital
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-001, Ver3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.